January 11, 2017 - By Vivian Park · 0 Comments
Stryker Corp (NYSE:SYK) institutional sentiment decreased to 0.79 in 2016 Q3. Its down -0.14, from 0.93 in 2016Q2. The ratio dived, as 309 active investment managers increased or opened new holdings, while 389 cut down and sold their holdings in Stryker Corp. The active investment managers in our partner’s database now have: 277.33 million shares, down from 279.01 million shares in 2016Q2. Also, the number of active investment managers holding Stryker Corp in their top 10 holdings decreased from 51 to 45 for a decrease of 6. Sold All: 46 Reduced: 343 Increased: 244 New Position: 65.
Stryker Corporation is a medical technology company. The company has a market cap of $47.56 billion. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. It has a 28.28 P/E ratio. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries.
About 2.40 million shares traded hands or 76.47% up from the average. Stryker Corporation (NYSE:SYK) has risen 8.27% since June 7, 2016 and is uptrending. It has outperformed by 0.85% the S&P500.
Analysts await Stryker Corporation (NYSE:SYK) to report earnings on January, 24. They expect $1.76 EPS, up 12.82% or $0.20 from last year’s $1.56 per share. SYK’s profit will be $674.94M for 17.62 P/E if the $1.76 EPS becomes a reality. After $1.39 actual EPS reported by Stryker Corporation for the previous quarter, Wall Street now forecasts 26.62% EPS growth.
According to Zacks Investment Research, “Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services.”
Greenleaf Trust holds 81.14% of its portfolio in Stryker Corporation for 26.49 million shares. Tukman Grossman Capital Management Inc owns 922,600 shares or 8.39% of their US portfolio. Moreover, Cabot has 7.79% invested in the company for 82,711 shares. The -based Bonness Enterprises Inc has invested 7.6% in the stock. Fundsmith Llp, a United Kingdom-based fund reported 4.14 million shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 2 buys, and 62 sales for $84.98 million net activity.
Ratings analysis reveals 63% of Stryker Corporation’s analysts are positive. Out of 19 Wall Street analysts rating Stryker Corporation, 12 give it “Buy”, 3 “Sell” rating, while 4 recommend “Hold”. The lowest target is $88 while the high is $130. The stock’s average target of $109.83 is -11.44% below today’s ($124.02) share price. SYK was included in 27 notes of analysts from July 27, 2015. The stock has “Neutral” rating given by Robert W. Baird on Wednesday, April 13. The stock has “Hold” rating given by Needham on Monday, September 28. Argus Research maintained Stryker Corporation (NYSE:SYK) rating on Wednesday, April 27. Argus Research has “Buy” rating and $130 price target. BMO Capital Markets upgraded the shares of SYK in a report on Tuesday, November 1 to “Market Perform” rating. The stock has “Outperform” rating given by Credit Suisse on Monday, August 10. The firm has “Buy” rating given on Friday, October 14 by Suntrust Robinson. The stock of Stryker Corporation (NYSE:SYK) earned “Underperform” rating by BMO Capital Markets on Monday, December 14. The rating was initiated by UBS on Tuesday, September 22 with “Neutral”. Goldman Sachs downgraded Stryker Corporation (NYSE:SYK) on Friday, November 13 to “Neutral” rating. The rating was initiated by Barclays Capital on Monday, April 11 with “Underweight”.
Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Firm offers its products to doctors, hospitals and other healthcare facilities. The Company’s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, and neurosurgical, neurovascular and spinal devices, as well as other medical device products used in a range of medical specialties. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. The Firm offers a 1588 advanced imaging modalities (AIM) platform, which is designed for optimum visualization across surgical specialties.
More recent Stryker Corporation (NYSE:SYK) news were published by: Twst.com which released: “Stryker Corporation: Stryker provides 2016 preliminary net sales results” on January 10, 2017. Also Mlive.com published the news titled: “Stryker to build $130-million corporate campus in Portage, add 105 jobs” on December 20, 2016. Areadevelopment.com‘s news article titled: “Stryker Corporation’s instruments division plans to establish a new 485000 …” with publication date: December 28, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park